The value and practical utility of intraoperative touch imprint cytology of sentinel lymph node(s) in patients with breast cancer: A retrospective cytology-histology correlation study.

Breast cancer Frozen section Sentinel lymph node Tough imprint cytology

Journal

CytoJournal
ISSN: 0974-5963
Titre abrégé: Cytojournal
Pays: United States
ID NLM: 101231642

Informations de publication

Date de publication:
2020
Historique:
received: 15 07 2019
accepted: 09 09 2019
entrez: 18 6 2020
pubmed: 18 6 2020
medline: 18 6 2020
Statut: epublish

Résumé

Intraoperative evaluation of sentinel lymph nodes (SLNs) for patients with breast cancer is widely performed with frozen section (FS), cytology, or a combination of both. Touch imprint cytology (TIC) reportedly has an equivalent sensitivity to FS. We studied its diagnostic utility to detect SLN metastases. Cases of 367 patients with breast cancer who underwent intraoperative valuation of SLNs (507 LNs) were evaluated. All FS and corresponding TIC slides of SLNs of each case were reviewed microscopically for the presence of metastases of any size. If present, the metastatic focus was measured on the FS. Of these 507 SLNs, 82 LNs (16.2%) from 69 women were found to have metastases in the FS and consisted of 5 LNs of isolated tumor cells, 15 of micrometastasis, and 62 of macrometastasis. TIC identified metastases in 69 of these 82 SLNs (sensitivity: 84.1%, specificity: 100%, and accuracy: 97.4%). All macrometastases could be detected by TIC, whereas TIC identified approximately 50% of micrometastases and none of isolated tumor cells. The size detection limit of metastatic foci, defined as the smallest dimension of metastasis detected without false negatives, was 2 mm. The smallest metastatic focus identified was 0.8 mm. TIC of SLNs is of great use given its negative predictive value of 100% for identification of macrometastasis in our study. For intraoperative evaluation of SLNs, based on our data, a practical two-step approach is proposed: SLN evaluation should be initially performed by TIC and then proceed to FS histological analysis only when cytologically positive to determine the size of metastatic focus.

Identifiants

pubmed: 32547631
doi: 10.25259/Cytojournal_80_2019
pii: Cytojournal-17-11
pmc: PMC7294180
doi:

Types de publication

Journal Article

Langues

eng

Pagination

11

Informations de copyright

©2020 Cytopathology Foundation Inc, Published by Scientific Scholar.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Arch Histol Cytol. 2003 May;66(2):123-43
pubmed: 12846553
JAMA. 2011 Feb 9;305(6):569-75
pubmed: 21304082
Am J Surg. 2015 Feb;209(2):240-5
pubmed: 25236187
Am J Surg. 2010 Jun;199(6):792-6
pubmed: 19954770
Pol J Pathol. 2010;61(3):161-5
pubmed: 21225499
World J Surg. 2010 Oct;34(10):2325-32
pubmed: 20567971
Ann Surg. 2004 Jan;239(1):61-6
pubmed: 14685101
Histopathology. 2016 Jan;68(1):152-67
pubmed: 26768036
Ann Surg. 1999 Apr;229(4):536-41
pubmed: 10203087
Lancet Oncol. 2010 Oct;11(10):927-33
pubmed: 20863759
Asian J Surg. 2004 Oct;27(4):294-8
pubmed: 15564182
J Natl Compr Canc Netw. 2019 Feb;17(2):118-126
pubmed: 30787125
Diagn Cytopathol. 2018 Nov;46(11):919-926
pubmed: 30353679
Br J Surg. 2006 May;93(5):572-6
pubmed: 16550634
Ann R Coll Surg Engl. 2009 May;91(4):336-9
pubmed: 19344553
Ann Surg Oncol. 2012 Oct;19(10):3144-51
pubmed: 22847123

Auteurs

Yuji Uno (Y)

Department of Diagnostic Pathology, Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan.

Naoko Akiyama (N)

Department of Diagnostic Pathology, Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan.

Sayaka Yuzawa (S)

Department of Diagnostic Pathology, Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan.

Masahiro Kitada (M)

Breast Center, Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan.

Hidehiro Takei (H)

Department of Diagnostic Pathology, Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan.

Classifications MeSH